Christopher Griffith
Papers
1
Total Citations
37
H-Index
1
About
Dr. Christopher Griffith is a leading head and neck pathologist whose research focuses on refining risk stratification in human papillomavirus (HPV)-associated oropharyngeal squamous cell carcinoma (OPSCC). His seminal 2018 study, cited 37 times, critically challenged clinical dogma by demonstrating that radiographic imaging cannot reliably predict macroscopic extranodal extension (ENE) in this patient population. This work has profound implications for treatment de-escalation trials, as it underscores the necessity of pathologic confirmation over radiologic assessment for accurate staging. Dr. Griffith’s broader contributions center on integrating histopathologic biomarkers with clinical outcomes to better identify patients who may safely avoid aggressive therapy. His research is instrumental in moving the field toward more personalized, de-intensified treatment protocols for HPV-positive OPSCC, ultimately aiming to reduce long-term toxicity without compromising survival. Through his meticulous pathologic analyses and collaborative clinical studies, Dr. Griffith has become a key voice in the multidisciplinary management of head and neck cancer, helping to bridge the gap between pathology and radiation oncology.
Research Focus
Key Achievements
Top Papers
- 1